WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.

CLSI AST News Update | June 2018


CLSI's Subcommittee on Antimicrobial Susceptibility Testing (AST) Outreach Working Group has published Volume 3, Issue 2 of their biannual AST News Update (Spring 2018).

Inside This Issue:

  • Featured Article: Part 1
    New β-lactam combination agents for the treatment of Gram-negative bacterial infections: what the clinical microbiologist needs to know!
    By Stephanie L. Mitchell, University of Pittsburgh and Children’s Hospital of Pittsburgh, and Romney M. Humphries, Accelerate Diagnostics
  • Featured Article: Part 2
    Why all the fuss over quality control of β-lactam combination agents?
    By Janet A Hindler, UCLA Health System; Los Angeles County Department of Health
  • Case Study:
    Cefazolin, Urine, and Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis: Entertaining Solutions for Antimicrobial Susceptibility Testing and Reporting
    By Audrey N. Schuetz, Mayo Clinic, and Stella Antonara, Nationwide Children’s Hospital
  • Burning Question:
    What Should Clinical Laboratorians Know About Gonorrhea in 2018?
    By Peera Hemarajata, Los Angeles County Department of Public Health, Angella Charnot-Katsikas, University of Chicago, and Sumanth Gandra, University of Chicago/NorthShore University Health System
  • Hot Topic:
    It’s Enough to mec You Crazy!
    By Lars Westblade, Weill Cornell Medicine

You can view the entire AST News Update here.


← Go Back